Gut APC and Open Access: BMJ's Gastroenterology Flagship at a Reasonable Price

Gut is a hybrid journal. That means you have two publication routes:

1. Subscription track (default, $0): Your article goes behind the paywall on gut.bmj.com. Institutional subscribers access it through their library. You pay nothing.
2. Gold open access track (~$3,500): Your article is immediately free for anyone to read under a Creative Commons license. You or your funder/institution pays the APC.

Most research published in Gut still follows the subscription route. The journal has a large subscriber base through medical libraries and gastroenterology departments worldwide, so your paper reaches its core audience either way.

One thing worth knowing: BMJ has a relatively generous approach to making subscription content accessible. Research articles in BMJ titles often become free to access on the publisher's website after a variable period, typically 6-12 months. This isn't the same as gold OA (no Creative Commons license), but it means the practical access difference between subscription and OA narrows over time.

BMJ Publishing Group has strong institutional coverage, particularly in the UK. The most important deal is the Jisc agreement, which covers all UK universities and NHS trusts.

For UK researchers, the path is simple. Your paper gets accepted, you select the gold OA option during production, and the Jisc agreement covers the APC automatically. You don't process a payment. This makes Gut one of the easiest top gastroenterology journals for UK-based researchers to publish in on an open access basis.

Outside the UK, coverage is less uniform. US institutions have been slower to establish BMJ agreements compared to Springer Nature or Elsevier deals, partly because BMJ's journal portfolio is smaller. If you're at a US institution and want OA in Gut, check with your library first. Don't assume your existing Elsevier or Springer Nature deal extends to BMJ titles.

BMJ's waiver system is clear and predictable:

Automatic geographical waivers:

• Full APC waiver for corresponding authors from low-income countries (World Bank classification).
• 50% reduction for authors from lower-middle-income countries.

Case-by-case waivers:

• Available for researchers who face genuine financial hardship and have no institutional or funder support.
• Requests are considered after acceptance. Editorial decisions are independent of waiver applications.

NHS research:

• Some BMJ titles offer reduced rates for NHS-funded research. This is specific to UK health service studies and reflects BMJ's historical connection to the British Medical Association.

The waiver system follows the same World Bank framework that Springer Nature uses, which makes it predictable. If you qualify based on your country, the discount is automatic. You don't have to negotiate.

Gut supports both CC BY and CC BY-NC licenses for open access articles. Plan S funders require CC BY. If your funder is a cOAlition S member, make sure you select CC BY at the licensing stage. Choosing CC BY-NC won't satisfy Plan S requirements.

For NIH-funded researchers, the green route works: publish via subscription for free, then deposit the accepted manuscript in PubMed Central after the embargo period. This is a common path for US-based gastroenterologists who don't have institutional BMJ agreements.

UKRI-funded researchers at UK institutions have the smoothest experience. The Jisc agreement covers the APC, the journal supports CC BY natively, and compliance is automatic. This is one of the clearest advantages of publishing in a BMJ title over an Elsevier or Cell Press journal from a UK institution.

Gut has a distinctive editorial identity within gastroenterology. The journal publishes across the full spectrum of GI and hepatology research, but it has particular strength in:

• Microbiome research: Gut has been one of the leading journals for microbiome studies since the field exploded in the early 2010s. It published several landmark studies linking gut microbiota to metabolic disease.

• IBD: Inflammatory bowel disease research is a core area for the journal, including clinical trials, pathogenesis studies, and epidemiology.

• GI oncology: Upper and lower GI cancers, screening studies, and early detection.

• Hepatology: Despite being a general GI journal, Gut publishes substantial liver disease research, competing directly with Hepatology and Journal of Hepatology.

The journal's acceptance rate sits around 10-12%, making it selective but not as extreme as Nature or Cell (which reject 90%+ at the desk). Gut typically provides initial decisions within 3-4 weeks, which is faster than several competitors.

Gut is published by BMJ on behalf of the British Society of Gastroenterology. The journal has been in continuous publication since 1960, giving it over 65 years of history in the field. It's indexed in PubMed, Scopus, Web of Science, and all standard databases.

For current APC rates and author guidelines, visit the official Gut author information page.

Gut doesn't charge submission fees, page fees, or color figure surcharges. The APC is the only publication-related charge. But watch for these:

• Currency fluctuations: APCs are in GBP. If your grant budget is in USD or EUR, exchange rate movements can shift the effective cost by 5-10% between submission and acceptance.

• VAT for UK institutions: UK-based payments include 20% VAT. The Jisc agreement handles this automatically, but if you're paying out of pocket, a £2,700 APC becomes £3,240.

• Data sharing costs: BMJ has increasingly strong data sharing policies. Clinical trial data must be made available, and preparing datasets for sharing takes staff time even if repository deposit is free.

• Reprints: Physical reprints are charged separately. Most researchers don't need these, but some promotion committees still ask for them.

• Statistical review revisions: Gut has rigorous statistical review. If your analysis needs revision, the time cost of re-running analyses and revising methods sections can be substantial, though this isn't a journal fee.

Gut's cost equation is straightforward:

1. UK institution? Publish OA for free through the Jisc agreement. This is the simplest route.
2. Plan S funder, non-UK institution? Pay ~$3,500 for gold OA. This is cheaper than Gastroenterology or Journal of Hepatology.
3. NIH-funded, no OA mandate pressure? Publish via subscription for free. Deposit in PMC after the embargo.
4. Budget-conscious? The subscription track costs $0, and Gut's subscriber base ensures your paper reaches the GI community.

Gut offers a rare combination: a high-impact specialty journal with affordable OA pricing and strong institutional coverage. It's one of the best value propositions in gastroenterology publishing.

Before submitting, make sure your manuscript meets Gut's editorial standards. The journal is selective, and a desk rejection wastes time you could spend targeting the right venue. Gut submission readiness check to identify formatting, statistical, and structural issues before your paper reaches the editors. For a broader look at BMJ's portfolio pricing, see our BMJ APC breakdown.

Worth paying if:

• Your funder mandates open access (check Plan S / cOAlition S requirements)
• An institutional Read & Publish agreement covers the fee
• Open access visibility meaningfully benefits your research area
• The APC fits within your grant budget

Consider alternatives if:

• The APC is a personal out-of-pocket expense
• A subscription option or green OA (preprint + embargo) satisfies your funder
• Another OA journal with a lower APC would provide similar visibility